[This corrects the article DOI: 10.1371/journal.pone.0297905.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11684608 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0316856 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Correction: A cross-sectional survey benchmarking the coverage and importance of obesity-related competencies in U.S. dietetic supervised practice programs.
BMC Med Educ
December 2024
Bariatric and Metabolic Institute, Director of Obesity Medicine, Cleveland Clinic, Cleveland, OH, USA.
Definition of hyperfiltration taking into account age-related decline in renal function in kidney donor candidates with obesity and glucose tolerance disorder.
Hypertens Res
December 2024
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
The definition of hyperfiltration, the main pathogenesis in renal impairment in obesity and diabetes mellitus, is uncertain. Glomerular filtration rate (GFR) declines physiologically with aging, and there is inaccuracy in GFR in obesity due to body surface area (BSA) correction. Here, we defined hyperfiltration using GFR without BSA correction, but with inclusion of aging, and investigated hyperfiltration using this definition and absolute GFR > 125 mL/min.
View Article and Find Full Text PDFObesity-Related Kidney Disease in Bariatric Surgery Candidates.
Obes Surg
January 2025
Department of Nephrology, Unidade Local de Saúde de Santo António, (ULS Santo António), Porto, Portugal.
Article Synopsis
- Obesity adversely affects kidney health, but the specific kidney dysfunction markers in bariatric surgery candidates are not well understood, prompting a study comparing these biomarkers to those of living kidney donors.
- The study involved matching 200 bariatric candidates with 200 living kidney donors based on sex and age, using a 24-hour urine collection to assess protein levels and kidney function.
- Findings indicated that patients with obesity had higher creatinine clearance and proteinuria than kidney donors, underscoring the need to reconsider how kidney function is evaluated in obese individuals considering bariatric surgery, particularly regarding body surface area adjustments.
Semaglutide-induced weight loss improves mitochondrial energy efficiency in skeletal muscle.
bioRxiv
November 2024
Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, UT, USA.
Objective: Glucagon-like peptide 1 receptor agonists (e.g. semaglutide) potently induce weight loss and thereby reducing obesity-related complications.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!